Insider trading

Period: 120 months Stock: ALNY + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

220 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

220 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

220 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

220 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
220 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
220 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

220 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 Jun 2025
Greenstreet Yvonne Chief Executive Officer
Sold on a plan
$5.90M 19,297 at 306.00
28.3%
Planned (10b5-1)
30 May 2025
Greenstreet Yvonne Chief Executive Officer
Sold on a plan 2×
$9.63M 31,640 at 304.39
39.3%
Planned (10b5-1)
15 May 2025
BONNEY MICHAEL W Director
Sold on a plan 14×
$3.12M 11,250 at 277.71
40.1%
Planned (10b5-1)
16 Apr 2025
Reitan Colleen F Director
Sold at will
$8.38K 36 at 232.86
100%
Sold half or more
24 Mar 2025
PYOTT DAVID E I Director
Sold on a plan
$2.22M 7,440 at 299.00
98.2%
Sold half or more
24 Mar 2025
Garg Pushkal CMO & EVP Dev & Med Affairs
Sold on a plan
$1.63M 5,445 at 300.00
21.2%
Planned (10b5-1)
21 Mar 2025
Garg Pushkal CMO & EVP Dev & Med Affairs
Sold on a plan
$1.23M 4,321 at 285.00
17.6%
Planned (10b5-1)
4 Mar 2025
Fitzgerald Kevin Joseph CSO & EVP, Head of Research
Sold on a plan 4×
$203.53K 844 at 241.15
5.9%
Planned (10b5-1)
4 Mar 2025
Garg Pushkal CMO & EVP Dev & Med Affairs
Sold on a plan 4×
$194.77K 808 at 241.05
3.2%
Planned (10b5-1)
3 Mar 2025
Greenstreet Yvonne Chief Executive Officer
Sold at will 7×
$945.16K 3,877 at 243.79
3.8%
Not planned
3 Mar 2025
Fitzgerald Kevin Joseph CSO & EVP, Head of Research
Sold on a plan 10×
$465.77K 1,911 at 243.73
11.8%
Planned (10b5-1)
3 Mar 2025
Garg Pushkal CMO & EVP Dev & Med Affairs
Sold on a plan 10×
$426.38K 1,749 at 243.79
6.5%
Planned (10b5-1)
3 Mar 2025
Poulton Jeffrey V. EVP, Chief Financial Officer
Sold at will 7×
$308.14K 1,264 at 243.78
2.6%
Not planned
3 Mar 2025
Tanguler Tolga EVP, Chief Commercial Officer
Sold at will 6×
$114.82K 471 at 243.78
1.7%
Not planned
28 Feb 2025
Greenstreet Yvonne Chief Executive Officer
Sold at will 8×
$700.89K 2,900 at 241.69
3.3%
Not planned
28 Feb 2025
Garg Pushkal CMO & EVP Dev & Med Affairs
Sold at will 8×
$225.98K 935 at 241.69
6.7%
Not planned
28 Feb 2025
Poulton Jeffrey V. EVP, Chief Financial Officer
Sold at will 8×
$192.39K 796 at 241.70
2.3%
Not planned
28 Feb 2025
Tanguler Tolga EVP, Chief Commercial Officer
Sold at will 8×
$123.98K 513 at 241.68
3.5%
Not planned
28 Feb 2025
Fitzgerald Kevin Joseph CSO & EVP, Head of Research
Sold at will 8×
$119.88K 496 at 241.69
3.9%
Not planned
18 Feb 2025
Garg Pushkal CMO & EVP Dev & Med Affairs
Sold on a plan 6×
$389.58K 1,548 at 251.67
11.4%
Planned (10b5-1)
18 Feb 2025
Fitzgerald Kevin Joseph CSO & EVP, Head of Research
Sold on a plan 5×
$362.24K 1,440 at 251.56
10.1%
Planned (10b5-1)
14 Feb 2025
Garg Pushkal CMO & EVP Dev & Med Affairs
Sold on a plan 12×
$398.32K 1,561 at 255.17
10.3%
Planned (10b5-1)
14 Feb 2025
Greenstreet Yvonne Chief Executive Officer
Sold at will 12×
$309.53K 1,213 at 255.17
1.5%
Not planned
14 Feb 2025
Poulton Jeffrey V. EVP, Chief Financial Officer
Sold at will 12×
$246.75K 967 at 255.17
2.9%
Not planned
14 Feb 2025
Fitzgerald Kevin Joseph CSO & EVP, Head of Research
Sold on a plan 12×
$169.20K 663 at 255.21
4.4%
Planned (10b5-1)
27 Jan 2025
Garg Pushkal CMO & EVP Dev & Med Affairs
Sold on a plan
$14.99M 52,592 at 285.00
81.4%
Sold half or more
23 Jan 2025
SHARP PHILLIP A Director
Sold on a plan
$3.09M 11,250 at 275.00
100%
Sold half or more
12 Dec 2024
Garg Pushkal CMO & EVP Dev & Med Affairs
Sold on a plan 7×
$439.76K 1,752 at 251.00
10.0%
Planned (10b5-1)
27 Nov 2024
Fitzgerald Kevin Joseph CSO & EVP, Head of Research
Sold on a plan 4×
$386.26K 1,531 at 252.29
10.6%
Planned (10b5-1)
26 Nov 2024
Greenstreet Yvonne Chief Executive Officer
Sold at will 5×
$1.31M 5,219 at 250.98
6.2%
Not planned
26 Nov 2024
Poulton Jeffrey V. EVP, Chief Financial Officer
Sold at will 5×
$422.14K 1,682 at 250.98
5.2%
Not planned
26 Nov 2024
Garg Pushkal CMO & EVP Dev & Med Affairs
Sold at will 5×
$422.14K 1,682 at 250.98
8.8%
Not planned
26 Nov 2024
Tanguler Tolga EVP, Chief Commercial Officer
Sold at will 5×
$368.69K 1,469 at 250.98
10.0%
Not planned
26 Nov 2024
Fitzgerald Kevin Joseph CSO & EVP, Head of Research
Sold on a plan 5×
$368.69K 1,469 at 250.98
9.3%
Planned (10b5-1)
17 Oct 2024
Reitan Colleen F Director
Bought
$1.21K 4 at 302.67
12.5%
29 Aug 2024
Reitan Colleen F Director
Bought
$9.15K 32 at 286.00
opened
First buy on file
20 Aug 2024
Greenstreet Yvonne Chief Executive Officer
Sold on a plan
$4.20M 15,000 at 280.00
17.0%
Planned (10b5-1)
12 Aug 2024
Fitzgerald Kevin Joseph CSO & EVP, Head of Research
Sold on a plan 6×
$5.97M 22,025 at 270.99
63.1%
Sold half or more
6 Aug 2024
Sold on a plan 7×
$5.31M 20,250 at 262.00
99.3%
Sold half or more
1 Aug 2024
Greenstreet Yvonne Chief Executive Officer
Sold on a plan
$4.09M 15,148 at 270.00
17.1%
Planned (10b5-1)
11 Jul 2024
Greenstreet Yvonne Chief Executive Officer
Sold on a plan
$1.85M 7,093 at 261.00
8.8%
Planned (10b5-1)
25 Jun 2024
SCHULMAN AMY W Director
Sold on a plan
$2.04M 8,500 at 240.00
50.2%
Sold half or more
25 Jun 2024
Greenstreet Yvonne Chief Executive Officer
Sold at will 12×
$1.92M 8,301 at 230.99
9.3%
Not planned
25 Jun 2024
Garg Pushkal CMO & EVP Dev & Med Affairs
Sold at will 12×
$485.77K 2,103 at 230.99
11.9%
Not planned
25 Jun 2024
Poulton Jeffrey V. EVP, Chief Financial Officer
Sold at will 12×
$370.75K 1,605 at 231.00
5.3%
Not planned
25 Jun 2024
Tanguler Tolga EVP, Chief Commercial Officer
Sold at will 12×
$370.75K 1,605 at 231.00
12.1%
Not planned
25 Jun 2024
Fitzgerald Kevin Joseph CSO & EVP, Head of Research
Sold at will 12×
$276.73K 1,198 at 230.99
7.8%
Not planned
24 Jun 2024
PYOTT DAVID E I Director
Sold on a plan 3×
$7.16M 32,450 at 220.69
99.6%
Sold half or more
29 May 2024
SCHULMAN AMY W Director
Sold on a plan 3×
$3.22M 21,700 at 148.60
72.0%
Sold half or more
29 Feb 2024
SHARP PHILLIP A Director
Sold on a plan 6×
$4.54M 30,000 at 151.34
100%
Sold half or more
Showing 51–100 of 220. ← Newer Page 2 of 5 Older →